The New York Times recently published an excellent story illustrating what causes vaccine hesitancy and how to effectively combat it. Is the media finally learning that forcing shots on people doesn't work?
Reporters and science communicators commonly point to widespread COVID misinformation to explain why so many people are skeptical of vaccines and other infection-control measures. Bad pandemic takes clearly influence the public, but there's much more to the story.
Another study has found that lotteries didn't boost COVID vaccine uptake last year. Here's a few reasons why these giveaways probably didn't work.
As Omicron continues to infect its way across America, let us not forget its viral companion: influenza. How is that working out?
It was pretty much a forgone conclusion, but the FDA's decision to grant an Emergency Use Authorization to Pfizer's COVID drug, Paxlovid, could mark the turning point in our battle against the virus. Here's the story that you won't find anywhere in the press.
While COVID-19 vaccinations are increasing (however slowly), infections are increasing more rapidly. Both provide a degree of immunity from further infection. We have previously investigated daily rates of change in detail. Here we consider the cumulative rates of infection and the implications for the future of the pandemic.
Science journalism is plagued by several critical problems that jeopardize its credibility. If we want the public to be more science-minded, we have to correct these issues sooner rather than later.
It's no secret that yet another nasty COVID variant has emerged; omicron is spreading even faster than delta and there will be consequences. And other variants will surely emerge. Where? Impossible to say, but its name will be pi. Should this happen in the US, we might get stuck with a catchy, but unwanted name.
The last month has divided conventional wisdom. If cases continue to decline, the pandemic might be on its way out. If they trend upward, another winter surge might be on its way. Here we look for clues from data  through November 15, focusing on vaccination.
Several superficially plausible arguments against COVID-19 vaccination continue to pop up across the internet, usually phrased as leading questions. Are they as solid as they seem? A little investigation suggests they are mostly speculation.
Research has shown that adverse events following COVID-19 vaccination are very rare. Another large study of VAERS reports strengthens this conclusion.
Antiviral drugs will be a necessary addition to vaccines to tamp down COVID. Both Pfizer and Merck have drugs in the clinic and they both look good. Roche also has a candidate but things are looking pretty grim. How grim? Better read this.